New drug could finally stop deadly fatty liver disease
4 Articles
4 Articles
New drug could finally stop deadly fatty liver disease
Scientists at UC San Diego have unveiled a potentially game-changing treatment for MASH, a severe fatty liver disease affecting millions worldwide. The experimental drug, ION224, blocks a liver enzyme that drives fat buildup and inflammation, two key forces behind liver damage. In clinical trials, patients showed striking improvements in liver health, even without losing weight.
Researchers at the University of Michigan developed a new drug called DT-109, which demonstrated efficacy in the reversal of fatty liver disease in animal models. Innovation stands out for its role in intestinal health, a crucial factor in the treatment of liver damage. Discovered new treatment for liver disease The DT-109 drug was tested in animal studies and showed the ability to reverse associated metabolic steatosis (MASH), a severe form of …
MSNBCTV NEWS
solacenews.infoNew drug reverses severe fatty liver disease by repairing the gut
An experimental drug developed at Michigan Medicine has reversed a serious form of fatty liver disease in animal studies by targeting an unexpected source of liver damage: the gut. The compound, known as DT-109, works by reducing harmful gut bacteria, protecting the intestinal lining, and preventing inflammatory substances from reaching the liver. According to findings […]
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
